3Suppliers
3Customers
3Debt Items
20Related Chains

Mangoceuticals, Inc. Suppliers

TickerNameConfidenceEvidence
BRIGHTERMD-LLC-DBA-DOCTEGRITY BRIGHTERMD-LLC-DBA-DOCTEGRITY 92% The Company has entered into a Physician Services Agreement with BrighterMD, LLC dba Doctegrity ("Doctegrity") to provide online telemedicine technology services to the Company.
MANGO-DAT-LLC MANGO-DAT-LLC 92% The Agreement and the Order Form are by and between Mango DAT, LLC and Cube Operations LLC
AEGIS-CAPITAL-CORP AEGIS-CAPITAL-CORP 90% In connection with the Offering, the Company also entered into a placement agency agreement (the "Placement Agency Agreement") with Aegis Capital Corp. (the "Placement Agent"), pursuant to which the …

Mangoceuticals, Inc. Customers

TickerNameConfidenceEvidence
CUBE-OPERATIONS-LLC CUBE-OPERATIONS-LLC 92% The Agreement and the Order Form are by and between Mango DAT, LLC and Cube Operations LLC
BRIGHTERMD-LLC BRIGHTERMD-LLC 85% tains control of the products upon the Company’s completion of its performance obligation. The Company has entered into a Physician Services Agreement with BrighterMD, LLC dba Doctegrity (“Doctegrity…
NAVY-WHARF-LTD NAVY-WHARF-LTD 85% . Renewal beyond the initial 3-year term cannot be guaranteed. Fair value of distribution rights based on discounted cash flows over the initial term is less than the $ 1,362,447 carrying value. An i…

Mangoceuticals, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
MGRX-DEBT Debt stack $307,823 90% Market cache reports total debt of $307,823.
MGRX-DEBT-10964 Xbrl Convertible 90% xbrl convertible detail from xbrl 2025-12-31.
MGRX-DEBT-10963 Warrants outstanding: 2000000 90% xbrl warrant detail from xbrl 2025-12-31.

Mangoceuticals, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Mangoceuticals, Inc..

Mangoceuticals, Inc. Ownership

HolderNameConfidenceEvidence
MGRX-OWNER-JANE-STREET-GROUP-LLC Jane Street Group, LLC 95% 13F/ownership overlay lists Jane Street Group, LLC; shares held 47,503; ownership 0.29%; value $23,148; as of 2025-12-31.
MGRX-OWNER-ACKERMAN-CAPITAL-ADVISORS-LLC Ackerman Capital Advisors, LLC 95% 13F/ownership overlay lists Ackerman Capital Advisors, LLC; shares held 34,500; ownership 0.21%; value $16,811; as of 2025-12-31.
MGRX-OWNER-ARMISTICE-CAPITAL-LLC Armistice Capital, LLC 95% 13F/ownership overlay lists Armistice Capital, LLC; shares held 1,536,000; ownership 9.43%; value $748,492; as of 2025-12-31.
MGRX-OWNER-VANGUARD-GROUP-INC Vanguard Group Inc 95% 13F/ownership overlay lists Vanguard Group Inc; shares held 489,532; ownership 3.01%; value $238,548; as of 2025-12-31.
MGRX-OWNER-IKARIAN-CAPITAL-LLC Ikarian Capital, LLC 95% 13F/ownership overlay lists Ikarian Capital, LLC; shares held 138,146; ownership 0.85%; value $67,318; as of 2025-12-31.
MGRX-OWNER-GEODE-CAPITAL-MANAGEMENT-LLC Geode Capital Management, LLC 95% 13F/ownership overlay lists Geode Capital Management, LLC; shares held 108,322; ownership 0.67%; value $52,785; as of 2025-12-31.
MGRX-OWNER-UBS-GROUP-AG UBS Group AG 95% 13F/ownership overlay lists UBS Group AG; shares held 46,167; ownership 0.28%; value $22,497; as of 2025-12-31.
MGRX-OWNER-NORTHERN-TRUST-CORPORATION Northern Trust Corporation 95% 13F/ownership overlay lists Northern Trust Corporation; shares held 37,579; ownership 0.23%; value $18,312; as of 2025-12-31.
MGRX-OWNER-VIRTU-FINANCIAL-LLC Virtu Financial LLC 95% 13F/ownership overlay lists Virtu Financial LLC; shares held 33,462; ownership 0.21%; value $16,306; as of 2025-12-31.
MGRX-OWNER-BOOTHBAY-FUND-MANAGEMENT-LLC Boothbay Fund Management, LLC 95% 13F/ownership overlay lists Boothbay Fund Management, LLC; shares held 38,441; ownership 0.24%; value $18,732; as of 2025-12-31.
MGRX-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC VANGUARD CAPITAL MANAGEMENT LLC 90% 13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 18 tracked holders.

Mangoceuticals, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
SNNUF Smith & Nephew plc 100.00 2
NVO Novo Nordisk A/S 100.00 2
CSTE Caesarstone Ltd. 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
ALC Alcon Inc. 100.00 2
CTNM Contineum Therapeutics, Inc. 100.00 2
EDSA Edesa Biotech, Inc. 100.00 2
BLLN BillionToOne, Inc. 100.00 2
DAWN Day One Biopharmaceuticals Inc 100.00 2
AXSM Axsome Therapeutics, Inc. 100.00 2
AORT Artivion, Inc. 100.00 2
AVBP ArriVent BioPharma, Inc. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
FHTX Foghorn Therapeutics Inc. 100.00 2
ANIK Anika Therapeutics, Inc. 100.00 2
AKTS Aktis Oncology, Inc. 100.00 2
BNR Burning Rock Biotech Limited 100.00 2
BNRG Brenmiller Energy Ltd 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
ATRA Atara Biotherapeutics, Inc. 100.00 2